Terms Defined Elsewhere. As used in this Agreement, the following capitalized terms are defined in this Agreement as referenced in the following table: Definition Section Agreement Preamble Amendment to the Company Management Agreement Recitals Articles of Merger 2.2(b) Book-Entry Shares 3.3(b)(i) Cancelled Shares 3.1(b)(v) Certificate of Merger 2.2(b) Certificates 3.3(b)(i) Closing 2.2(a) Closing Date 2.2(a) Code Recitals Company Preamble 2 Definition Section Company Additional Dividend Amount 6.19(a) Company Affiliate 9.10(a) Company Board Recitals Company Board Recommendation Recitals Company Change of Recommendation 6.3(b) Company Common Stock 3.1(b)(i) Company Contracts 3.2(b) Company DER Consideration 3.2(b) Company Director Designee 2.6 Company Disclosure Letter Article IV Company Dividend Equivalent Right 3.2(b) Company Material Adverse Effect 4.1(a) Company Permits 4.9 Company Plans 4.10(a) Company SEC Documents 4.5(a) Company Series A Preferred Stock 3.1(b)(iii) Company Series B Preferred Stock 3.1(b)(iii) Company Series C Preferred Stock 3.1(b)(iii) Company Special Committee Recitals Company Stockholders Recitals Company Stockholders Meeting 4.4 Confidentiality Agreement 6.7(b) Creditors’ Rights 4.3(a) Delaware LLC Act 2.1 Delaware Secretary of State 2.2(b) e-mail 9.3 Effective Time 2.2(b) End Date 8.1(b)(ii) Exchange Agent 3.3(a) Exchange Fund 3.3(a) Forfeited Phantom Shares 3.2(a) GAAP 4.5(b) Indemnified Liabilities 6.10(a) Indemnified Persons 6.10(a) Joint Proxy Statement 4.4 Letter of Transmittal 3.3(b)(i) Leverage Covenants 6.1(a)(xiv) Maryland Courts 9.7(b) Maryland Department 2.2(b) Material Company Insurance Policies 4.17 Material Parent Insurance Policies 5.17 Merger Recitals Merger Filings 2.2(b) Merger Sub Preamble Merger Sub Sole Member Recitals Definition Section MGCL 2.1 Operating Partnership 2.1 Parent Preamble Parent Additional Dividend Amount 6.19(b) Parent Affiliate 9.10(b) Parent Board Recitals Parent Board Recommendation 5.3(a) Parent Change of Recommendation 6.4(b) Parent Common Stock Issuance Recitals Parent Contracts 5.16(b) Parent Disclosure Letter Article V Parent Equity Plan 5.2(a) Parent Management Agreement Amendment Recitals Parent Manager Recitals Parent Material Adverse Effect 5.1(a) Parent Permits 5.9 Parent Plans 5.10(a) Parent SEC Documents 5.5(a) Parent Stock Issuance Recitals Parent Stockholders Recitals .pdf 9.5 Per Share Common Merger Consideration 3.1(b)(i) Per Share Preferred Merger Consideration 3.1(b)(iii) Per Share Preferred Se...
Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below:
Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: Acceptance Time Section 1.1(e) Aggregate Xxxxxx Payable Amount Section 1.1(f)(iii) Agreement Preamble Bankruptcy Cases Section 5.9 Company Preamble Company Board of Directors Recitals Company Board Recommendation Recitals Company Disclosure Letter Article II Company Party Section 1.1(f)(iii) Company Shares Recitals D&O Insurance Section 5.4(c) Enforceability Limitations Section 2.3(b) Equity Award Cash Consideration Section 1.1(h) Equity Award Xxxxxx Payment Section 1.1(h) Exculpation and Indemnification Agreements Section 5.4(b) Indemnified Parties Section 5.4(a) Annex A-5 Xxxxxx Section 1.1(f)(iii) Xxxxxx Claim Section 1.1(f)(iii) Offer Recitals Offer Conditions Section 1.1(a)(iv) Offer to Purchase Section 1.1(a)(iii) Outside Date Section 6.1(d) Party Preamble Per Member Xxxxxx Payable Amount Section 1.1(f)(i) Per Share Xxxxxx Payable Amount Section 1.1(f)(ii) Process Agent Section 7.9(c) Prospector Rig Acquisition Section 5.9 Purchaser Preamble Purchaser Disclosure Letter Article III Tail Period Section 5.4(c) Tender Offer Consideration Section 1.1(a)(ii) Tendering Members Recitals Termination Payment Section 6.2(b) Annex A-6 Annex B List of Tendering Members The information contained on this page has been redacted for confidentiality purposes. Annex B-1 The information contained on this page has been redacted for confidentiality purposes. The information contained on this page has been redacted for confidentiality purposes, other than the totals listed below. Total 3,407,072 67.90% *Percentages are rounded off to the nearest second decimal point and are calculated based on 5,017,556 total outstanding Shares as of the date hereof. Annex B-3 Annex C Form of Offer to Purchase (see attached) The attachment to this Annex C has been intentionally omitted. Annex X-0 Xxxxx X Xxx Xxxxxxxx Xxxxxxxx Xx the date falling 5 days before the agreed date for the Acceptance Time and again immediately prior to the Acceptance Time, the Company shall provide Purchaser with responses to each of the following inquiries from the rig manager of each of the Prospector Rigs via electronic mail (from a company or ship email address):
Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: Term Section 2010 Earnout Amount Section 2.2.1 2010 Earnout Period Section 2.2.1 2011 Earnout Amount Section 2.2.2 2011 Earnout Period Section 2.2.2 Acceleration Event Section 2.2.7 Acknowledgments Section 8.1 Aggregate Stock Consideration Section 2.1.2 Agreement Preamble Alternative Financing Section 5.21.1 Antitrust Division Section 5.12.1 Articles of Merger Section 1.3 Audited Financial Statements Section 3.7.1 Authorized Action Section 9.3 Bond Financing Section 5.21.1 Bonus Earnout Amount Section 2.2.3 Cash-Out Shares Section 2.1.7 Certificate of Merger Section 1.3 Certificates Section 2.7.3 Claim Section 9.2 Closing Section 1.2 Closing Balance Sheet Section 2.6.1 Closing Date Section 1.2 Closing Payment Certificate Section 2.5 Closing Statement Section 2.6.1 Code Recitals Company Preamble Company Articles of Incorporation Section 3.2 Company Basket Section 8.6.2 Company Benefit Plan Section 3.10.1 Company Bylaws Section 3.2 Company Disclosure Schedule Article III Term Section Company Employees Section 5.15.1 Company Financial Statements Section 3.7.1 Company Indemnified Person Section 8.2 Company Indemnifying Party Section 8.1 Company Material Contract Section 3.12.1 Company MNPI Section 5.21.2 Company Permits Section 3.6 Company RSU Section 2.4 Company SARs Section 2.3 Company Subsidiary Section 3.1 Company Subsidiaries Section 3.1 Company Transfers Section 5.1 Confidentiality Agreement Section 5.9.2 Conversion Section 2.1.1 D&O Indemnitee Section 5.16.2 Damages Section 8.3 Defaulting Party Section 7.2.1.3 Delaware Secretary of State Section 1.3 Disclosed Financing Letters Section 4.31 Dissenter Rights Section 2.9 Dissenter Shares Section 2.9
Terms Defined Elsewhere. The following terms are defined in this Agreement as follows: “Agreement” Preamble
Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: 401(k) Termination Date Section 7.7(c) Acceptance Time Section 1.1(f) Adjusted Option Section 3.4(b) Adjusted RSU Section 3.4(d) Agreement Preamble Arrangements Section 7.14 Book-Entry Shares Section 3.2(b) Cancelled Shares Section 3.1(b) Certificates Section 3.2(b) Change of Recommendation Section 6.3(a) Closing Section 2.2 Closing Date Section 2.2 COBRA Section 4.10(d) Company Preamble Company Benefit Plans Section 4.10(a) Company Board of Directors Recitals Company Board Recommendation Recitals Company Capitalization Date Section 4.2(a) Company Common Stock Recitals Company Compensation Committee Section 7.14 Company Disclosure Letter Article IV Company Equity Schedule Section 4.2(b) Company Permits Section 4.9(b) Company Preferred Stock Section 4.2(a) Company SEC Documents Section 4.5(a) Company Shares Recitals Company Stockholders Recitals Convertible Senior Notes Section 7.15 DGCL Recitals Dissenting Shares Section 3.3(a) DOJ Section 7.2(b) Enforceability Limitations Section 4.3(c) Exchange Agent Section 3.2(a) Exchange Fund Section 3.2(a) Fractional Share Consideration Section 3.1(a) FTC Section 7.2(b) GAAP Section 4.5(b) Indemnified Parties Section 7.4(a) Indenture Section 7.15 Intervening Event Section 6.3(d) Material Contract Section 4.17(a) Minimum Condition Section 1.1(a)(i)
Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: “Affected Employees” Section 6.8(a) “Agreement” Preamble “Appraisal Rights” Section 2.3(a) “Base Premium” Section 6.5(d) “Book-Entry Shares” Section 2.2(b) “Certificate of Merger” Section 1.3 61 “Certificates” Section 2.2(b) “Change in Control Agreements” Section 6.8(d) “Change of Recommendation” Section 5.2(a) “Closing” Section 1.2 “Closing Date” Section 1.2 “Common Stock” Section 3.2(a) “Company” Preamble “Company Board of Directors” Recitals “Company Board Recommendation” Recitals “Company Disclosure Letter” Article III “Company Equity Awards” Section 2.4(c) “Company Equity Plan” Section 2.4(a) “Company Financial Advisor” Section 3.20 “Company Options” Section 2.4(a) “Company Permits” Section 3.18(b) “Company SEC Documents” Section 3.6 “Covered Persons” Section 6.5(b) “Debt Commitment Letter” Section 4.7 “DGCL” Recitals “Dissenting Shares” Section 2.3(a) “Effective Time” Section 1.3 “Equity Interests” Section 3.2(b) “Exchange Act” Section 1.6 “Exchange Fund” Section 2.2(a) “FCPA” Section 3.25 “Financial Statements” Section 3.6 “GAAP” Section 3.6 “Governmental Consents” Section 6.3(a) “Governmental Entity” Section 3.5 “HSR Act” Section 3.5 “Indemnification Agreements” Section 6.5(a) “Leases” Section 3.11(b) “Leased Real Property” Section 3.11(b) “Legal Proceeding” Section 3.13 “Match Period” Section 5.2(d) “Merger” Recitals “Merger Consideration” Recitals “Notice of Superior Proposal or Intervening Event” Section 5.2(d) “Offer” Recitals “Option Consideration” Section 2.4(a) “Outside Date” Section 8.1(c)
Terms Defined Elsewhere. In addition to the terms defined in Section 1.1, each of the following terms is defined in the Section set forth opposite such term: Term Section Agreement Preamble Assumption Agreement 4.2(a)(ii) Assets 2.2 Assumed Contracts 2.2(b) Assumed Liabilities 2.4 Audits 5.6 Xxxx of Sale 4.2(a)(i) Buyer Preamble Buyer Cap 8.6(b) Buyer Parties 8.1 Buyer Losses 8.1 Claim Notice 8.3 Claims Period 8.7 Closing 4.1 Confidential Information 7.4 Effective Date Preamble Excluded Assets 2.3 Excluded Contracts 2.5(c) Excluded Liabilities 2.5 Leased Real Property 5.10(b) Material Contracts 5.10(c) Offer of Employment 7.2(a) Open Source Materials 5.11(n) Parties Preamble Personal Property Leases 5.10(a) Pre-Closing Receivables 2.2(g) Proposed Contract 4.3 Real Property Leases 5.10(b) Related Party 5.19(a) Response Period 8.4(a) Required Approvals 4.3 Seller Preamble Seller Cap 8.6(a) Seller Insurance Policies 5.12 Seller Parties 8.2 Seller Losses 8.2 Third Party Action 8.4(a) Third Party Action Notice 8.4(a) Transferred Employee 7.3(a)
Terms Defined Elsewhere. The following terms are defined herein in the sections identified below:
Terms Defined Elsewhere. Each of the following terms is defined in the Section set forth opposite such term: Term Section Acceptable Company Confidentiality Agreement 6.02(b) Acceptable Parent Confidentiality Agreement 7.02(b) Agreement Preamble Ancillary Scheme Documentation 3.01(b) Assumed Company Option 2.03(a) Assumed Company RSU 2.03(c) Bankruptcy and Equity Exceptions 4.02(a) Benefits Continuation Period 8.03(a) Capitalization Date 4.05(a) Closing 1.02 Closing Date 1.02 Company Preamble Company 401(k) Plan 8.03(c) Company Adverse Recommendation Change 6.02(a) Company Approval Time 6.02(b) Company Board Recitals Company Board Recommendation 4.02(b) Company Directors 2.05(d) Company Exchange Fund 2.01(b) Company Material Contract 4.15(a) Company Material Subsidiaries 4.06(a) Company Organizational Document 4.01 Company Permits 4.12 Company Registered IP 4.19(a) Company Regulatory Agency 4.14(a) Company Regulatory Permits 4.14(a) Company Retention Plan 8.03(d) Company SEC Documents 4.07(a) Company Termination Payment 10.03(a) Term Section Conditions 8.06(b)(iii) Continuing Employees 8.03(a) Court Documentation 3.02(a)(i) Court Sanction Hearing 3.02(b)(i) Depositary Custodian 2.01(b) EC 4.14(a) Effective Date 1.03 Effective Time 1.03 EMA 4.14(a) End Date 10.01(b)(i) Exchange Agent 2.01(b) Exchange Ratio 2.02(a) FDA 4.14(a) FDCA 4.14(a) Foreign Antitrust Laws 4.03 Forms of Proxy 3.01(b) HMRC 4.03 HMRC Clearance 4.03 Indemnified Party 7.03(b) Intended U.S. Tax Treatment 8.07(b) internal controls 4.07(f) Leases 4.20 Maximum Amount 7.03(c) MHRA 4.14(a) Nasdaq 4.03 New Company Plans 8.03(b) Non-U.S. Plan 4.17(j) Offer Document 8.06(b)(i) Other Required Filing 3.01(c) Panel 4.25 Parent Preamble Parent Adverse Recommendation Change 8.04 Parent Approval Time 7.02(b) Parent Board Recitals Parent Board Recommendation 5.02(b) Parent Material Contract 5.14(a) Parent Option 2.03(a) Parent Organizational Documents 5.01 Parent Registered IP 5.17(a) Parent Regulatory Agency 5.13(a) Parent Regulatory Permits 5.13(a) Parent RSU 2.03(c) Parent SEC Documents 5.06(a) Parent Share Issuance 3.01(a) Parent Stockholder Meeting 3.01(a) Term Section Parent Stockholders 3.01(a) Parent Termination Payment 10.03(b) Parties Preamble Per ADS Share Deliverable 2.01(a) PHSA 4.14(a) Proxy Statement 3.01(a) Real Properties 4.20 Registration Statement 8.06(b)(i) Regulation S-K 4.10 Schedule 14D-9 8.06(b)(ii) Scheme Document Annex 3.01(a) Scheme Technical Defect 3.05(b)(i) Second Request 8.02(c) Share Consideration ...
